From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.
The Testing Policies are for health professionals ordering hepatitis C and hepatitis B tests and receiving, interpreting and delivering results to patients. They set out a framework for providing quality testing and removing real and perceived barriers to testing.
The web based provision of the policies allows for regular revision and access to related resources with download and print functions.
Expert Reference Committees guide the development and updating of each testing policy.